The Journal of Heart and Lung Transplantation
Volume 23, Issue 6 , Pages 657-665 , June 2004

Myocardial and endothelial protection for heart transplantation in the new millenium: lessons learned and future directions

  • Friedhelm Beyersdorf, MD, FETCS

      Affiliations

    • Corresponding Author InformationReprint requests: Friedhelm Beyersdorf, MD, Department of Cardiovascular Surgery, Albert-Ludwigs-University Freiburg, Hugstetterasse 55, Freiburg/Brsg. D-79106, Germany. Telephone: 0049-761-270-2818. Fax: 0049-761-270-2550.
    • Department of Cardiovascular Surgery, Albert-Ludwigs-University Freiburg, Freiburg, Germany

Received 16 July 2003 ,Revised 28 August 2003 ,Accepted 5 September 2003.

References 

  1. Davierwala PM, Maganti M, Yau T. Decreasing significance of left ventricular dysfunction and redo surgery in predicting CABG mortality: a 12 year study. J Thorac Cardiovasc Surg (in press).
  2. Kirklin JW, Barratt-Boyes BG. Cardiac surgery. In: New York: Churchill Livingstone; 1993;p. 149
  3. Kirklin JK, Naftel DC, Bourge DC, et al.  Evolving trends in risk profiles and causes of death after heart transplantation (A ten year multi-institutional study). J Thorac Cardiovasc Surg. 2003;125:881–890
  4. Bourge RC, Kirklin JK, Naftel DC, McGiffin DC. Predicting outcome after cardiac transplantation (Lessons from the cardiac transplant research database). Curr Opin Cardiol. 1997;12:136–145
  5. Hertz MI, Taylor DO, Trulock EP, et al.  The registry of the International Society for Heart and Lung Transplantation (Nineteenth official report—2002). J Heart Lung Transplant. 2002;21:950–970
  6. Reichenspurner H, Russ C, Überfuhr P, Nollert G, Schluter A, Reichert B, et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. Eur J Cardiothorac Surg. 1993;7:414–419
  7. Aziz T, Burgess M, Rahman AN, Campbell CS, Yonan N. Cardiac transplantation for cardiomyopathy and ischemic heart disease (Differences in outcome up to 10 years). J Heart Lung Transplant. 2001;20:525–533
  8. Demmy TL, Biddle JS, Bennet LE, Walls JT, Schmaltz RA, Curtis JJ. Organ preservation solutions in heart transplantation—patterns of usage and related survival. Transplantation. 1997;63:262–267
  9. Pearl JM, Drinkwater DC, Laks H, Stein DG, Capouya ER, Bhuta S. Leucocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res. 1992;52:298–308
  10. Pearl JM, Drinkwater DC, Laks H, Capouy ER, Gates RN. Leukocyte-depleted reperfusion of transplanted hearts (A randomized, double-blind clinical trial). J Heart Lung Transplant. 1992;11:1082–1092
  11. Buckberg GD. Invited letter (Phase of myocardial protection during transplantation). J Thorac Cardiovasc Surg. 1990;100:461–462
  12. Martin J, Sarai K, Yoshitake M, Haberstroh J, Takahashi N, Lutter G, et al. Orthotopic transplantation of pig hearts harvested after 30 minutes of normothermic ischemia (Controlled reperfusion with blood cardioplegia containing the na+–h+-exchange inhibitor hoe 642). Eur J Cardiothorac Surg. 1998;14:607–614
  13. Martin J, Sarai K, Yoshitake M, Haberstroh J, Takahashi N, Lutter G, et al. Successful orthotopic pig heart transplantation from non-heart-beating donors. J Heart Lung Transplant. 1999;18:597–606
  14. Martin J, Lutter G, Ihling C, Siepe M, Wagner S, Sarai K, Beyersdorf F. Myocardial viability 24 hours after orthotopic heart transplantation from non-heart-beating donors. J Thorac Cardiovasc Surg 2003;125:1217–28.
  15. Buckberg GD. Myocardial protection (Entering the new millenium). J Cardiac Surg. 2002;17:447–450
  16. Beyersdorf F, Mitrev Z, Ihnken K, Schmiedt W, Sarai K, Eckel L, et al. Controlled limb reperfusion in patients having cardiac operations. J Thorac Cardiovasc Surg. 1996;111:873–881
  17. Beyersdorf F. Surgical management to avoid severe post-reperfusion syndrome (“controlled limb reperfusion”). Transplant Proc. 1995;27:2795–2798
  18. Halldorsson A, Kronon M, Allen BS, Bolling KS, Wang T, Rahman SK, et al.  Controlled reperfusion after lung ischemia (Implications for improved function after lung transplantation). J Thorac Cardiovasc Surg. 1998;115:415–425
  19. DeMeo DL, Ginns LC. Clinical status of lung transplantation. Transplantation. 2001;11:1713–1724
  20. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans (A systematic review of recent publications). J Heart Lung Transplant. 2002;21:271–281
  21. Fiser SM, Kron IL, Long SM, et al.  Controlled perfusion decreases reperfusion injury after high-flow reperfusion. J Heart Lung Transplant. 2002;21:687–691
  22. Julia P, Haab F, Sabatier B, Fuzellier JF, Nochy D, Cambillau M, et al.  Improvement of postischemic kidney function by reperfusion with a specifically developed solution (BT01). Ann Vasc Surg. 1995;9(suppl):S81–S88
  23. Allen BS, Veluz JS, Buckberg GD, Aeberhard E, Ignarro LJ. Deep hypothermic circulatory arrest and global reperfusion injury (Avoidance by making a pump prime reperfusion—a new concept). J Thorac Cardiovasc Surg. 2003;125:625–632
  24. Parolari A, Rubini P, Cannata A, Bonati L, Alamanni F, Tremoli E, et al. Endothelial damage during myocardial preservation and storage. Ann Thorac Surg. 2002;73:682–690
  25. Buckberg GD. Endothelial and myocardial stunning. J Thorac Cardiovasc Surg. 2003;125(suppl):S92–S93
  26. Kofsky ER, Julia BL, Buckberg GD, Quillen JA, Acar C. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition (Effects of leucocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion). J Thorac Cardiovasc Surg. 1991;101:350–359
  27. Yamamoto H, Moriyama Y, Hisatomi K, Yotsumoto G, Taira A, Sakata R. A leukocyte depleting filter reduces endothelial cell dysfunction and improves transplanted canine heart function. J Heart Lung Transplant. 2001;20:670–678
  28. Fukushima N, Shirakura R, Nakata S, et al.  Study of efficacies of leucocyte-depleted terminal blood cardioplegia in 24-hour preserved hearts. Ann Thorac Surg. 1994;58:1651–1656
  29. Mitsuno A, Baretti R, Buckberg GD, Young H, Vinten-Johansen J, Ma X, et al.  Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle (A role of l-arginine blood cardioplegia). J Thorac Cardiovasc Surg. 1997;113:379–389
  30. Hiramatsu T, Forbess J, Miura T, Nomura F, Mayer JE. Additive effects of l-arginine infusion and leukocyte depletion on recovery after hypothermic ischemia in neonatal lamb hearts. J Thorac Cardiovasc Surg. 1995;110:172–179
  31. Kronon MT, Allen BS, Halldorson A, Rahman S, Wang T, Ilbawi M. Dose dependency of l-arginine in neonatal myocardial protection (The nitric oxide paradox). J Thorac Cardiovasc Surg. 1999;118:655–664
  32. DeVita MA, Snyder JV, Arnold RM, Siminoff LA. Observations of withdrawal of life-sustaining treatment from patients who became non-heart-beating organ donors. Crit Care Med. 2000;28:1709–1712
  33. Billia F, Carter K, Rao V, Gorezynski R, Feindel C, Ross HJ. Transforming growth-factor expression is significantly lower in hearts preserved with blood/insulin versus crystalloid cardioplegia. J Heart Lung Transplant. 2002;21:918–922
  34. Baldwin WR, Samaniego-Picota M, Kasper E, et al.  Complement deposition in early cardiac biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation. 1999;68:894–900
  35. Lee J, Drinkwater D, Laks H, et al.  Preservation of endothelium-dependent vasodilatation with low-potassium University of Wisconsin solution. J Thorac Cardiovasc Surg. 1996;112:103–110
  36. Kirklin J, McGiffin D. Control of the inflammatory response in extended myocardial preservation of the donor heart. Ann Thorac Surg. 1999;68:1978–1982
  37. John R, Rajasinghe H, Itescu S, et al.  Factors affecting long term survival (>10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol. 2001;37:189–194
  38. Harlan DM, Kirk AD. The future of organ and tissue transplantation. Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?. JAMA. 1999;282:1076–1082
  39. Faulk WP, Labarerre CA, Pitts D, Halbrook H. Vascular lesions in biopsy specimens devoid of cellular infiltrates (Qualitative and quantitative immunocytochemical studies of human cardiac allografts). J Heart Lung Transplant. 1993;12:219–229
  40. Labarrere CA, Nelson DR, Spear KL. Non-immunologic vascular failure of the transplanted heart. J Heart Lung Transplant. 2003;22:236–240
  41. Labarrere CA, Torry RJ, Nelson DR, et al.  Vascular antithrombin and clinical outcome in heart transplant patients. Am J Cardiol. 2001;87:425–431
  42. Labarrere CA, Pitts D, Nelson DR, Faulk WP. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med. 1995;333:1111–1116
  43. Labarrere CA, Nelson DR, Faulk WP. Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA. 1997;278:1169–1175
  44. Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy (Time for a reappraisal). J Heart Lung Transplant. 1997;16:743–751
  45. Benza RL. Commentary; Non-immunologic vascular failure of the transplanted heart. J Heart Lung Transplant. 2003;22:241–243
  46. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells (Expression of plasminogen activators and inhibitors in injured rat arteries). Circ Res. 1996;78:405–414
  47. Carmeliet P, Moons L, Ploplis VA, Plow E, Collen D. Impaired arterial neointima formation in mice with disruption of the plamsminogen gene. J Clin Invest. 1997;99:200–208
  48. Dengler TJ, Pober JS. Human vascular endothelial cells stimulate memory but not native CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol. 2000;164:5146–5155
  49. Rose EA, Pepino P, Barr ML, et al.  Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant. 1992;11(suppl):S120–S123
  50. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 1992;339:1566–1570
  51. Anyanwu AC, Banner NR, Mitchell AG, Khaghani A, Yacoub MH. Low incidence and severity of transplant-associated coronary artery disease in heart transplants from live donors. J Heart Lung Transplant. 2003;22:281–286
  52. Yacoub MH, Banner NR, Khaghani A, et al.  Heart–lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant. 1990;9:459–466
  53. Zaroff JG, Rosengard BR, Armstrong WF, et al.  Maximizing use of organs recovered from the cadaver donor (Cardiac recommendations). J Heart Lung Transplant. 2002;21:1153–1160
  54. Potter CDO, Wheeldon DR, Wallwork J. Functional assessment and management of heart donors (A rationale for characterization and a guide to therapy). J Heart Lung Transplant. 1995;14:59–65
  55. Stoica SC, Satchithananda DK, Charman S, et al.  Swan–Ganz catheter assessment of donor hearts (Outcome of organs with borderline hemodynamics). J Heart Lung Transplant. 2002;21:615–622
  56. Beyersdorf F, Acar C, Buckberg GD, et al.  Studies on prolonged acute regional ischemia. V. Metabolic support of remote myocardium during left ventricular power failure. J Thorac Cardiovasc Surg. 1989;98:567–579
  57. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery. Controversies and possible solutions. Ann Thorac Surg. 2003;75(suppl):745S–752S
  58. Takahashi A, Hearse DJ, Braimbridge MV, Chambers DJ. Harvesting hearts for long-term preservation (Detrimental effects of initial hypothermic infusion of cardioplegic solutions). J Thorac Cardiovasc Surg. 1990;100:371–378
  59. Michel P, Vial R, Rodriguez C, Ferrera R. A comparative study of the most widely used solutions for cardiac graft preservation during hypothermia. J Heart Lung Transplant. 2002;21:1030–1039
  60. Tixier D, Matheis G, Buckberg GD, Young HH. Donor hearts with impaired hemodynamics. J Thorac Cardiovasc Surg. 1991;102:207–214
  61. Stowe DF, Heisner JS, An J, et al.  Inhibition of Na+/H+ isoform-1 exchange protects the hearts perfused after 6-hour cardioplegic cold storage. J Heart Lung Transplant. 2002;21:374–382
  62. Castella M, Buckberg GD, Tan Z. Blood cardioplegic protection in profoundly damaged hearts (Role of na+-h+ exchange inhibition during pretreatment or during controlled reperfusion supplementation). Ann Thorac Surg. 2003;75:1238–1245
  63. Gharagozloo F, Melendez FJ, Heim RA, et al.  The effect of amino acid l-glutamate on the extended preservation ex vivo of the heart for transplantation. Circulation. 1987;76:65–70
  64. Choong YS, Gavin JB. l-asparate improves the functional recovery of explanted hearts stored in St. Thomas hospital cardioplegic solution at 4°C. J Thorac Cardiovasc Surg. 1990;99:510–517
  65. Choong YS, Gavin JB, Buckman J. Long-term preservation of explanted hearts perfused with l-aspartate-enriched cardioplegic solution. J Thorac Cardiovasc Surg. 1992;103:210–218
  66. Rosenkranz ER, Okamoto F, Buckberg GD, Robertson JM, Vinten-Johansen J, Bugyi HI. Safety of prolonged aoritc clamping with blood cardioplegia. III. Asparate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J Thorac Cardiovasc Surg. 1986;91:428–435
  67. Fremes SE, Li RK, Weisel RD, Mickle DAG, Tumiati LC. Prolonged hypothermic cardiac storage with University of Wisconsin solution. An assessment with human cell cultures. J Thorac Cardiovasc Surg. 1991;102:666–672
  68. Beyersdorf F, Allen BA, Buckberg GD. Integrated myocardial protection. In:  Franco KL,  Verrier ED editor. Advanced Therapy in cardiac surgery. New York: Marcel Dekker; 1999;p. 38–50
  69. Caus T, Desrois M, Izquierdo M, Lan C, et al.  NOS substrate during cardioplegic arrest and cold storage decreases stunning after heart transplantation in a rat model. J Heart Lung Transplant. 2003;22:184–191
  70. Nelson SK, Gao B, Bose S, Rizeq M, McCord JM. A novel heparin-binding, human chimeric, superoxide dismutase improves myocardial preservation and protects from ischemia-reperfusion injury. J Heart Lung Transplant. 2002;21:1296–1303
  71. Okamoto Y, Sugawara H, Minatoya Y, et al.  Recent experience of integrated myocardial management (The newest strategy for myocardial protection). Artif Org. 1997;21:798–802
  72. Loop FD, Higgins TL, Panda R, et al.  Myocardial protection during cardiac operations. J Thorac Cardiovasc Surg. 1992;104:608–618

PII: S1053-2498(03)00459-5

doi: 10.1016/j.healun.2003.09.009

The Journal of Heart and Lung Transplantation
Volume 23, Issue 6 , Pages 657-665 , June 2004

Article Tools